@inproceedings{pagani-2021-ensidnet,
    title = "{E}n{S}id{N}et: Enhanced Hybrid {S}iamese-Deep Network for grouping clinical trials into drug-development pathways",
    author = "Pagani, Lucia",
    editor = "Toutanova, Kristina  and
      Rumshisky, Anna  and
      Zettlemoyer, Luke  and
      Hakkani-Tur, Dilek  and
      Beltagy, Iz  and
      Bethard, Steven  and
      Cotterell, Ryan  and
      Chakraborty, Tanmoy  and
      Zhou, Yichao",
    booktitle = "Proceedings of the 2021 Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies",
    month = jun,
    year = "2021",
    address = "Online",
    publisher = "Association for Computational Linguistics",
    url = "https://preview.aclanthology.org/fix-sig-urls/2021.naacl-main.24/",
    doi = "10.18653/v1/2021.naacl-main.24",
    pages = "254--266",
    abstract = "Siamese Neural Networks have been widely used to perform similarity classification in multi-class settings. Their architecture can be used to group the clinical trials belonging to the same drug-development pathway along the several clinical trial phases. Here we present an approach for the unmet need of drug-development pathway reconstruction, based on an Enhanced hybrid Siamese-Deep Neural Network (EnSidNet). The proposed model demonstrates significant improvement above baselines in a 1-shot evaluation setting and in a classical similarity setting. EnSidNet can be an essential tool in a semi-supervised learning environment: by selecting clinical trials highly likely to belong to the same drug-development pathway it is possible to speed up the labelling process of human experts, allowing the check of a consistent volume of data, further used in the model{'}s training dataset."
}